Materials and methods for treatment of hereditary haemochromatosis
AssigneeCrispr Therapeutics AG
InventorsRoman Lvovitch Bogorad, Chad Albert Cowan, Ante Sven Lundberg
Life of this patent
Estimating the term…
Abstract
Materials and methods for treating a patient with hereditary hemochromatosis (HHC), both ex vivo and in vivo, and materials and methods for modulating the expression, function, or activity of a haemochromatosis (HFE) gene in a cell by genome editing.
Claims34
A method for editing a haemochromatosis (HFE) gene in a human cell by genome editing, the method comprising:
- introducing into the human cell one or more deoxyribonucleic acid (DNA) endonucleases to effect one or more single-strand breaks (SSBs) or double-strand breaks (DSBs) within or near the HFE gene or other DNA sequences that encode regulatory elements of the HFE gene that results in a permanent deletion, insertion, correction, or modulation of expression or function of one or more mutations within or near or affecting the expression or function of the HFE gene and results in restoration of HFE protein activity.
A method for inserting a haemochromatosis (HFE) gene in a human cell by genome editing, the method comprising:
- introducing into the human cell one or more deoxyribonucleic acid (DNA) endonucleases to effect one or more single-strand breaks (SSBs) or double-strand breaks (DSBs) within or near a safe harbor locus that results in a permanent insertion of the HFE gene, and results in restoration of HFE protein activity.
-22. (canceled)
An in vivo method for treating a patient with hereditary hemochromatosis (HHC), the method comprising the step of editing a haemochromatosis (HFE) gene in a cell of the patient or other DNA sequences that encode regulatory elements of the HFE gene, or editing within or near a safe harbor locus in a cell of the patient.
-29. (canceled)
(canceled)
(canceled)
(canceled)
-47. (canceled)
-55. (canceled)
-58. (canceled)
(canceled)
One or more guide ribonucleic acids (gRNAs) for editing a haemochromatosis (HFE) gene in a cell from a patient with hereditary hemochromatosis (HHC), the one or more gRNAs comprising a spacer sequence selected from the group consisting of nucleic acid sequences in SEQ ID NOs:
- 1-64,980 of the Sequence Listing.
-66. (canceled)
Dependencies are inferred from the claim text.